Key facts
- This page summarizes Robert J. Polzer's Form 4 filing for Zoetis Inc. (ZTS).
- 5 reported transactions and 3 derivative rows are listed below.
- Accepted by SEC: 26 Nov 2024, 16:27.
Robert J. Polzer - 25 Nov 2024 Form 4 Insider Report for Zoetis Inc. (ZTS)
- Reporting relationship
- Executive Vice President
- Issuer ticker
- ZTS
- Reported as of
- 25 Nov 2024
- Net transaction value
- -$55,044
- SEC form
- 4
- Accepted by SEC
- 26 Nov 2024, 16:27:48 UTC
- Prior SEC filing
- 08 Oct 2024
- Next SEC filing
- 13 Jan 2025
- Source filing
- View source filing
- Reporting owner signature
- /s/ Brenda Santuccio, as Attorney-in-Fact
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Robert J. Polzer filed Form 4 for Zoetis Inc. (ZTS) on 26 Nov 2024.
Change
- Previous filing in this sequence was filed on 08 Oct 2024.
- Current net transaction value: -$55,044.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
ZTS
transaction
Common Stock
Options Exercise
- Transaction value
- $169,775
- Shares
- +1,057
- Change %
- +33%
- Price
- $160.62
- Shares after
- 4,306
- Date
- 25 Nov 2024
- Ownership
- Direct
ZTS
transaction
Common Stock
Options Exercise
- Transaction value
- $392,209
- Shares
- +2,420
- Change %
- +56%
- Price
- $162.07
- Shares after
- 6,726
- Date
- 25 Nov 2024
- Ownership
- Direct
ZTS
transaction
Common Stock
Sale
- Transaction value
- $617,028
- Shares
- -3,477
- Change %
- -52%
- Price
- $177.46
- Shares after
- 3,249
- Date
- 25 Nov 2024
- Ownership
- Direct
- Footnotes
- F1
ZTS
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 1,060
- Date
- 25 Nov 2024
- Ownership
- 401(k)
- Footnotes
- F2
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
ZTS
transaction
Derivative
Stock Option
Options Exercise
- Transaction value
- $0
- Shares
- -1,057
- Change %
- -16%
- Price
- $0.000000
- Shares after
- 5,455
- Date
- 25 Nov 2024
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 1,057
- Exercise price
- Footnotes
- F3, F4, F5, F6, F7
ZTS
transaction
Derivative
Stock Option
Options Exercise
- Transaction value
- $0
- Shares
- -2,420
- Change %
- -33%
- Price
- $0.000000
- Shares after
- 4,840
- Date
- 25 Nov 2024
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 2,420
- Exercise price
- $162.07
- Footnotes
- F6, F8, F9
ZTS
holding
Derivative
Stock Option
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 7,107
- Date
- 25 Nov 2024
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 7,107
- Exercise price
- $196.14
- Footnotes
- F6, F8, F10
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 10 footnotes
Footnote F1
The Price reported in Table I, Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $177.45 to $177.50, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Footnote F2
Represents the common stock equivalents held in the Zoetis Inc. Savings Plan, a 401(k) plan, as of September 30, 2024.
Footnote F3
Stock options (right to buy Zoetis Inc. common stock) granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan.
Footnote F4
1,057 options granted February 10, 2021 at an exercise price of $160.62 per option.
Footnote F5
Each option vests on the third anniversary of the date of grant.
Footnote F6
Each option expires on the tenth anniversary of the date of grant.
Footnote F7
5,455 options granted February 8, 2022 at an exercise price of $201.30 per option.
Footnote F8
Stock options (right to buy Zoetis Inc. common stock) granted pursuant to the Zoetis Inc. Amended and Restated 2013 Equity and Incentive Plan.
Footnote F9
One-third of each option vests on the first, second and third anniversaries of the date of grant, February 8, 2023.
Footnote F10
One-third of each option will vest on the first, second and third anniversaries of the date of grant, February 6, 2024.